<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01234714</url>
  </required_header>
  <id_info>
    <org_study_id>MRI_Steatosis_Outcomes</org_study_id>
    <nct_id>NCT01234714</nct_id>
  </id_info>
  <brief_title>Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications</brief_title>
  <acronym>MRsteatosis</acronym>
  <official_title>Liver Fat Quantification by Magnetic Resonance Imaging (MRI): A Novel Tool for Prediction of Postoperative Complications After Major Liver Resection?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to objectively quantify liver fat content (LFC) by Magnetic
      Resonant Imaging (MRI) prior to major liver surgery, and to investigate its association with
      post-operative complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lack of agreement exists among expert pathologists in the standard histological assessment of
      hepatic steatosis on biopsy. The impact of different grades of steatosis on postoperative
      complications after major liver resection remains controversial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Liver Fat Content on MRI in Patients With Serious Post-operative Complications (Clavien-Dindo Grade ≥IV)</measure>
    <time_frame>December 2010</time_frame>
    <description>Liver fat content, measured by MRI, uses the in-phase/out-of-phase imaging calculated in terms of fat signal fraction (FSF).
The Clavien-Dindo Classification of Surgical Complications:
Grade I: Any deviation from the normal postoperative course without the need for treatment. Grade II: Requiring pharmacological treatment with drugs. Grade III: Requiring surgical, endoscopic or radiological intervention. Grade IV: Life-threatening complication requiring IC/ICU-management. Grade V: Death of a patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Alanine Transaminase (ALT) Levels</measure>
    <time_frame>December 2010</time_frame>
    <description>Alanine Transaminase is commonly measured clinically as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-operative Blood Loss</measure>
    <time_frame>December 2010</time_frame>
    <description>Intra-operative blood loss was defined according to the total volume of blood loss from the beginning until the end of the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Time</measure>
    <time_frame>December 2010</time_frame>
    <description>The operation duration was measured according to the total minutes from the beginning of the operation until the end.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit (ICU) Stay</measure>
    <time_frame>December 2010</time_frame>
    <description>The Intensive Care Unit (ICU) stay was calculated according to the total number of days the patients were managed in the ICU. This included also multiple ICU admissions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>December 2010</time_frame>
    <description>The patient hospital stay was calculated according to the total number of days the patient was hospitalized.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>December 2010</time_frame>
    <description>The total in-hospital costs were calculated for each patient in Euros.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of Post-operative Complications</measure>
    <time_frame>December 2010</time_frame>
    <description>There are several different types of post-operative complications associated with liver surgery, such as liver failure, multi-organ failure, bleeding, bile leak, and sepsis.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">84</enrollment>
  <condition>Fatty Liver</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Major liver resection</arm_group_label>
    <description>This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonant Imaging (MRI) and underwent major liver resection (&gt;=3 segments).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-invasive Magnetic Resonance Imaging (MRI)</intervention_name>
    <description>Conventional pre-operative MRI</description>
    <arm_group_label>Major liver resection</arm_group_label>
    <other_name>Magnetic Resonance Imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Major liver resection</intervention_name>
    <description>Hepatectomy of &gt;= 3 liver segments</description>
    <arm_group_label>Major liver resection</arm_group_label>
    <other_name>Hepatectomy = liver resection by open surgery.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major liver resection (&gt;= 3 resected segments).

          -  Patients that received a pre-operative Magnetic Resonance Imaging (MRI).

          -  Patient over 18 years of age

        Exclusion Criteria:

          -  Patients that underwent liver surgery but &lt; 3 segments were resected (e.g. wedge liver
             resection).

          -  Patient that did not receive a pre-operative MRI

          -  Patient age less than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dimitri A Raptis, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Department of Visceral and Transplant Surgery, Zurich, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Zurich, Department of Interventional and Diagnostic Radiology</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.</citation>
    <PMID>19638912</PMID>
  </reference>
  <results_reference>
    <citation>Raptis DA, Fischer MA, Graf R, Nanz D, Weber A, Moritz W, Tian Y, Oberkofler CE, Clavien PA. MRI: the new reference standard in quantifying hepatic steatosis? Gut. 2012 Jan;61(1):117-27. doi: 10.1136/gutjnl-2011-300155. Epub 2011 Oct 13.</citation>
    <PMID>21997548</PMID>
  </results_reference>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2010</study_first_submitted>
  <study_first_submitted_qc>November 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2010</study_first_posted>
  <results_first_submitted>November 11, 2011</results_first_submitted>
  <results_first_submitted_qc>February 7, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 8, 2012</results_first_posted>
  <last_update_submitted>February 7, 2012</last_update_submitted>
  <last_update_submitted_qc>February 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fatty Liver</keyword>
  <keyword>Liver</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients that underwent liver surgery were recruited at the outpatient clinics.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Major Liver Resection</title>
          <description>This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonant Imaging (MRI) and underwent major liver resection (&gt;=3 segments).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Major Liver Resection</title>
          <description>This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonant Imaging (MRI) and underwent major liver resection (&gt;=3 segments).</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="84"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Liver Fat Content on MRI in Patients With Serious Post-operative Complications (Clavien-Dindo Grade ≥IV)</title>
        <description>Liver fat content, measured by MRI, uses the in-phase/out-of-phase imaging calculated in terms of fat signal fraction (FSF).
The Clavien-Dindo Classification of Surgical Complications:
Grade I: Any deviation from the normal postoperative course without the need for treatment. Grade II: Requiring pharmacological treatment with drugs. Grade III: Requiring surgical, endoscopic or radiological intervention. Grade IV: Life-threatening complication requiring IC/ICU-management. Grade V: Death of a patient</description>
        <time_frame>December 2010</time_frame>
        <population>According to the Clavien-Dindo Classification of surgical complications: (please see) http://www.surgicalcomplication.info/</population>
        <group_list>
          <group group_id="O1">
            <title>Clavien-Dindo Grade &lt;IV Complications</title>
            <description>Percentage of liver fat content on MRI in patients with Clavien-Dindo Grade &lt;IV complications.
No complications: Patients without any post-operative complications defined according to the Clavien-Dindo Classification.
Grade 1: Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside.
Grade II: Requiring pharmacological treatment with drugs other than such allowed for grade I complications.
Blood transfusions and total parenteral nutrition are also included.
Grade III:Requiring surgical, endoscopic or radiological intervention</description>
          </group>
          <group group_id="O2">
            <title>Clavien-Dindo Grade ≥IV Complications</title>
            <description>Percentage of liver fat content on MRI in patients with Clavien-Dindo Grade &lt;IV complications.
These are typically life-threatening complication (including CNS complications) requiring ICU management.
Grade IVa: single organ dysfunction (including dialysis)
Grade IVb: multi-organ dysfunction</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Liver Fat Content on MRI in Patients With Serious Post-operative Complications (Clavien-Dindo Grade ≥IV)</title>
          <description>Liver fat content, measured by MRI, uses the in-phase/out-of-phase imaging calculated in terms of fat signal fraction (FSF).
The Clavien-Dindo Classification of Surgical Complications:
Grade I: Any deviation from the normal postoperative course without the need for treatment. Grade II: Requiring pharmacological treatment with drugs. Grade III: Requiring surgical, endoscopic or radiological intervention. Grade IV: Life-threatening complication requiring IC/ICU-management. Grade V: Death of a patient</description>
          <population>According to the Clavien-Dindo Classification of surgical complications: (please see) http://www.surgicalcomplication.info/</population>
          <units>Percentage of liver fat content</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" lower_limit="0.5" upper_limit="4.2"/>
                    <measurement group_id="O2" value="13.6" lower_limit="7.6" upper_limit="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative Alanine Transaminase (ALT) Levels</title>
        <description>Alanine Transaminase is commonly measured clinically as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health.</description>
        <time_frame>December 2010</time_frame>
        <population>According to the MRI liver fat content measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Group With Liver Fat Content &lt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
          <group group_id="O2">
            <title>Patient Group With Liver Fat Content &gt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Alanine Transaminase (ALT) Levels</title>
          <description>Alanine Transaminase is commonly measured clinically as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health.</description>
          <population>According to the MRI liver fat content measurement.</population>
          <units>Units/liter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="386" lower_limit="262" upper_limit="486"/>
                    <measurement group_id="O2" value="1355" lower_limit="1277" upper_limit="1894"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intra-operative Blood Loss</title>
        <description>Intra-operative blood loss was defined according to the total volume of blood loss from the beginning until the end of the operation.</description>
        <time_frame>December 2010</time_frame>
        <population>According to MRI</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Group With Liver Fat Content &lt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
          <group group_id="O2">
            <title>Patient Group With Liver Fat Content &gt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
        </group_list>
        <measure>
          <title>Intra-operative Blood Loss</title>
          <description>Intra-operative blood loss was defined according to the total volume of blood loss from the beginning until the end of the operation.</description>
          <population>According to MRI</population>
          <units>ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="300" lower_limit="200" upper_limit="500"/>
                    <measurement group_id="O2" value="400" lower_limit="300" upper_limit="600"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Time</title>
        <description>The operation duration was measured according to the total minutes from the beginning of the operation until the end.</description>
        <time_frame>December 2010</time_frame>
        <population>According to MRI</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Group With Liver Fat Content &lt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
          <group group_id="O2">
            <title>Patient Group With Liver Fat Content &gt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time</title>
          <description>The operation duration was measured according to the total minutes from the beginning of the operation until the end.</description>
          <population>According to MRI</population>
          <units>min</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="323" lower_limit="240" upper_limit="405"/>
                    <measurement group_id="O2" value="360" lower_limit="300" upper_limit="420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intensive Care Unit (ICU) Stay</title>
        <description>The Intensive Care Unit (ICU) stay was calculated according to the total number of days the patients were managed in the ICU. This included also multiple ICU admissions.</description>
        <time_frame>December 2010</time_frame>
        <population>According to MRI</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Group With Liver Fat Content &lt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
          <group group_id="O2">
            <title>Patient Group With Liver Fat Content &gt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
        </group_list>
        <measure>
          <title>Intensive Care Unit (ICU) Stay</title>
          <description>The Intensive Care Unit (ICU) stay was calculated according to the total number of days the patients were managed in the ICU. This included also multiple ICU admissions.</description>
          <population>According to MRI</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Stay</title>
        <description>The patient hospital stay was calculated according to the total number of days the patient was hospitalized.</description>
        <time_frame>December 2010</time_frame>
        <population>According to MRI</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Group With Liver Fat Content &lt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
          <group group_id="O2">
            <title>Patient Group With Liver Fat Content &gt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Stay</title>
          <description>The patient hospital stay was calculated according to the total number of days the patient was hospitalized.</description>
          <population>According to MRI</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="10" upper_limit="16"/>
                    <measurement group_id="O2" value="19" lower_limit="14" upper_limit="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cost</title>
        <description>The total in-hospital costs were calculated for each patient in Euros.</description>
        <time_frame>December 2010</time_frame>
        <population>According to MRI</population>
        <group_list>
          <group group_id="O1">
            <title>Patient Group With Liver Fat Content &lt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
          <group group_id="O2">
            <title>Patient Group With Liver Fat Content &gt;10% on MRI</title>
            <description>Pre-operative Magnetic Resonance Imaging (MRI) liver fat content measurement (in percentage).</description>
          </group>
        </group_list>
        <measure>
          <title>Cost</title>
          <description>The total in-hospital costs were calculated for each patient in Euros.</description>
          <population>According to MRI</population>
          <units>Euros</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30363" spread="12701"/>
                    <measurement group_id="O2" value="83329" spread="86120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Type of Post-operative Complications</title>
        <description>There are several different types of post-operative complications associated with liver surgery, such as liver failure, multi-organ failure, bleeding, bile leak, and sepsis.</description>
        <time_frame>December 2010</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Time from MRI to patient hospital discharge after major liver resection.</time_frame>
      <desc>Serious and/or other [non-serious] adverse events were not collected/assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>Major Liver Resection</title>
          <description>This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonant Imaging (MRI) and underwent major liver resection (&gt;=3 segments).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Dimitri Aristotle Raptis, Principal Investigator</name_or_title>
      <organization>University of Zurich</organization>
      <phone>+41442553300</phone>
      <email>dimitri.raptis@usz.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

